Differences between adults and children: genetics and beyond

Area of Science:

• Gastroenterology and Immunology
• Pediatric Medicine
• Genetics

Background:

• Clinical and epidemiological studies reveal significant differences in disease course and phenotypes between pediatric inflammatory bowel disease (IBD) and adult-onset IBD.
• Therapeutic strategies for young-onset IBD differ, often involving earlier azathioprine use and cautious systemic steroid administration to mitigate impacts on growth and bone mineral density.
• These clinical distinctions have spurred extensive scientific and genetic research into pediatric IBD.

Purpose of the Study:

• To review and clarify key aspects of pediatric inflammatory bowel disease (IBD).
• To address common questions regarding the differences between pediatric and adult IBD.
• To provide concise information on the genetic underpinnings of very early-onset IBD.

Main Methods:

• Review of clinical observations and epidemiological studies on pediatric IBD.
• Analysis of genetic studies, including candidate gene and genome-wide association studies (GWAS) in pediatric IBD cohorts.
• Focus on genetic susceptibility and specific genetic defects, particularly in the IL10 signaling pathway.

Main Results:

• No significant differences in genetic susceptibility identified for pediatric IBD compared to adult IBD, except for very early-onset cases.
• Very early-onset IBD (before age 2) demonstrates a strong genetic basis.
• Defects in the Interleukin-10 (IL10) signaling pathway are a primary example of genetic causes in very early-onset IBD.

Conclusions:

• While general pediatric IBD shares genetic susceptibility with adult forms, very early-onset IBD represents a distinct genetic disorder.
• Genetic factors, especially IL10 pathway mutations, are crucial in the pathogenesis of IBD presenting before the age of two.
• Understanding these genetic differences is vital for targeted therapeutic approaches in young children with IBD.